Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SEI Medical PCLBKK:SEI 19 Return-on-Tangible-Equity is 9.97% as of Mar. 2026, which is 72% below its 10-year median of 36.01. GuruFocus rates BKK:SEI with a GF Score™ of 19/100. The stock has 3 warning signs investors should review. Among 112 Medical Distribution companies, SEI Medical PCL ranks better than 59.82% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. SEI Medical PCL's annualized net income for the quarter that ended in Mar. 2026 was ฿31.1 Mil. SEI Medical PCL's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ฿311.8 Mil. Therefore, SEI Medical PCL's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 9.97%.
The historical rank and industry rank for SEI Medical PCL's Return-on-Tangible-Equity or its related term are showing as below:
BKK:SEI'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 10.62 Med: 36.01 Max: 69.61
Current: 10.62
During the past 4 years, SEI Medical PCL's highest Return-on-Tangible-Equity was 69.61%. The lowest was 10.62%. And the median was 36.01%.
BKK:SEI's Return-on-Tangible-Equity is ranked better than 59.82% of 112
companies
in the Medical Distribution industry
Industry Median: 8.755
vs BKK:SEI: 10.62
SEI Medical PCL (BKK:SEI) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
SEI Medical PCL Return-on-Tangible-Equity Related Terms
SEI Medical PCL Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for SEI Medical PCL's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:SEI vs MCK, CAH, COR: Return-on-Tangible-Equity Comparison
For the Medical Distribution subindustry, SEI Medical PCL's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SEI Medical PCL Return-on-Tangible-Equity vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, SEI Medical PCL's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where SEI Medical PCL's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 9.97% mean?
SEI Medical PCL (BKK:SEI) has a Return-on-Tangible-Equity of 9.97% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on SEI Medical PCL and its competitors. This is 72% below median its historical median of 36.01. Over the past decade, SEI Medical PCL's Return-on-Tangible-Equity has ranged from 10.62 to 69.61. According to the industry distribution chart, SEI Medical PCL ranks #45 out of 112 companies in the Medical Distribution industry, placing it in the top 40.2%.
Is SEI Medical PCL's Return-on-Tangible-Equity too high?
SEI Medical PCL's current Return-on-Tangible-Equity of 9.97% is 72% below median its 10-year median of 36.01. Over the past 10 years, this metric has ranged from a low of 10.62 to a high of 69.61. The Medical Distribution industry median Return-on-Tangible-Equity is 8.76. SEI Medical PCL's value of 9.97% is 13.9% above this industry median. Based on the distribution chart, SEI Medical PCL ranks #45 out of 112 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, SEI Medical PCL has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does SEI Medical PCL's Return-on-Tangible-Equity compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, SEI Medical PCL ranks #45 out of 112 companies for Return-on-Tangible-Equity. This puts SEI Medical PCL in the upper half of its industry. The industry median Return-on-Tangible-Equity is 8.76. SEI Medical PCL's value of 9.97% is 13.9% above this benchmark. Historically, SEI Medical PCL's own Return-on-Tangible-Equity has ranged from 10.62 to 69.61 over the past decade. While the company's 10-year median is 36.01 vs. the industry median of 8.76, SEI Medical PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Distribution company?
The median Return-on-Tangible-Equity among Medical Distribution companies is 8.76, based on 112 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SEI Medical PCL's current Return-on-Tangible-Equity of 9.97% is 13.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on SEI Medical PCL and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Equity is 8.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SEI Medical PCL's current Return-on-Tangible-Equity is 9.97%, which is 72% below median its own 10-year median of 36.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SEI Medical PCL stock overvalued right now?
SEI Medical PCL (BKK:SEI) has a current Return-on-Tangible-Equity of 9.97%. The current Return-on-Tangible-Equity is 9.97%, which is 72% below median its 10-year median of 36.01 and 13.9% above the Medical Distribution industry median of 8.76. SEI Medical PCL's overall GF Score™ is 19/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For SEI Medical PCL (BKK:SEI), the current Return-on-Tangible-Equity is 9.97% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
SEI Medical PCL operates in the medical equipment and scientific products industry as a distributor and service provider of medical equipment. It has three reportable segments which are the sales of equipment related to scientific instruments and medical equipment, the related service segment and the medical equipment disposal segment. The main geographic which the company operates is Thailand. Key revenue is collected from the Disposal Segment.
19GF Score
Get the complete analysis for BKK:SEI
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SEI has been successfully added to your 
